Table 1.

Characteristics of the patients investigated in this study (for more details, see Supplementary Table 1)

	Age (y) [n = 319]	Tracer (MBq) [n = 319]	GSC [n = 284]	PSA at PET [n = 311]
Mean	67.6	168	7.5	161.0
SD	7.1	71.4	1.1	2347.6
Range	46-86	40–400	5–10	0.01–41395
Median	68	154	7	4.59
Prostatectomy		Radiation Therapya		ADT at PET
Yes = 226		Yes = 177		Yes = 86
No = 89		No = 125		No = 233
n/a = 4		n/a = 17		n/a = 0
PSA Doubling-Time [n/a: n = 127]
0–1 month (n = 30)	1–3 months (n = 52)	3–6 months (n = 36)	6–12 months (n = 34)	>1 year (n = 37)
Initial Pathological Stage (TNM) [Incomplete TNM: n = 44. n/a: n = 91]
pT1 pN0 (n = 4)	pT2 pN0 (n = 61)	pT3a pN0 (n = 30)	pT3b/pT4 + pN0 (n = 29)	any pT and pN+ (n = 60)

SD standard deviation

^aRadiation therapy of the prostate gland or of the prostate fossa after prostatectomy